휴온스
Financials
Valuation Metrics
휴온스's Market Cap is ₩2388B. At end of 2025 it was ₩3282B. Ranked #760 of 2,421 in KR market (top 31%), #338 of 1,640 on KOSDAQ (top 21%), #83 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 36%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 238.75B KRW | KR#760/2,421 Sec#83/231 |
| Revenue | 607.75B KRW | KR#554/2,421 Sec#24/231 |
| Net Income | 17.16B KRW | KR#768/2,421 Sec#52/231 |
| Total Assets | 650.03B KRW | KR#650/2,421 Sec#36/231 |
| Net Assets | 405.13B KRW | KR#591/2,421 Sec#36/231 |
| Employees | 1,049 | KR#246/2,421 Sec#17/231 |
| Value | ||
| P/E | 13.91x | KR#1,006/2,421 Sec#57/231 |
| P/B | 0.59x | KR#968/2,421 Sec#51/231 |
| PEG | 0.18x | KR#534/2,421 Sec#32/231 |
| P/S | 0.39x | KR#750/2,421 Sec#25/231 |
| EV/EBITDA | 15.79x | KR#884/2,421 Sec#53/231 |
| FCF Yield | 10.45% | KR#589/2,421 Sec#24/231 |
| Profitability | ||
| ROE | 4.24% | KR#1,189/2,421 Sec#83/231 |
| ROA | 2.64% | KR#1,099/2,421 Sec#82/231 |
| Op. Margin | 3.62% | KR#1,148/2,421 Sec#84/231 |
| Revenue Growth | 2.08% | KR#1,381/2,421 Sec#136/231 |
| Earnings Growth | 75.68% | KR#449/2,421 Sec#31/231 |
| Financial Health | ||
| Debt Ratio | 60.45% | KR#1,099/2,421 Sec#129/231 |
| Total Debt | 157.79B KRW | KR#590/2,421 Sec#31/231 |
| FCF | 24.95B KRW | KR#459/2,421 Sec#27/231 |
| Cash | 49.50B KRW | KR#742/2,421 Sec#43/231 |
| Current Ratio | 1.41x | KR#1,276/2,421 Sec#136/231 |
| Net Debt/EBITDA | 4.93x | KR#1,024/2,421 Sec#77/231 |
| Dividend | ||
| Div. Yield | 4.67% | KR#318/2,421 Sec#10/231 |
| Div. Growth | 46.03% | KR#268/2,421 Sec#10/231 |
| Performance | ||
| 1Y Return | -35.92% | KR#1,727/2,421 Sec#141/231 |
| 1M Return | -22.15% | KR#2,316/2,421 Sec#213/231 |
| From 52W High | -51.98% | KR#1,487/2,421 Sec#113/231 |
| 1Y MDD | -47.83% | KR#892/2,421 Sec#75/231 |
| Trading | ||
| Volume | 20,774 shares | KR#1,571/2,421 Sec#154/231 |
| Trading Value | 413.9M KRW | KR#1,003/2,421 Sec#101/231 |
| Foreign Own. | 16.06% | KR#294/2,421 Sec#17/231 |
| Per Share | ||
| EPS | 1,432 KRW | KR#582/2,421 Sec#40/231 |
| BPS | 33,819 KRW | KR#339/2,421 Sec#21/231 |
Company Info
Founded in 1965, the company re-listed on KOSDAQ in 2016 following a spin-off from Huons Global. It holds stakes in Huons N (health functional food company), Huons BioScience (pharmaceutical manufacturing), and PanGen (biosimilar EPO producer), which are slated for subsidiary incorporation in 2025. The professional pharmaceutical business supplies various professional pharmaceuticals domestically, while its beauty and well-being business expands into well-being pharmaceuticals, obesity treatments, medical devices, and health functional foods. Huons was established in 2016 and is headquartered in Seongnam-si, Gyeonggi-do.